Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.
Medical cannabis was rated as more positive in terms of emotional and holistic effects.
37% of GPs surveyed believe that medical cannabis has the potential to reduce patient dependency on other medications.
Catch up on some of the latest cannabis science.
The trial on non-cancer related chronic pain will recruit up to 5,000 patients.
Findings showed ‘significant improvement in self-reported pain levels’ in former professional athletes with chronic pain.
A new case study highlights the potential of cannabis for improving quality of life in patients with neuropathic pain.
A new online cannabis clinic for chronic pain management has launched through primary healthcare provider, The GP Service. Cannabis company, Kanabo Group, announced the launch of...
Opioid use decreased following cannabis therapy and this decline grew more significantly over time.
More than half of those surveyed said it helped them to reduce their use of other pain medications.